Thomas Harbo

6.2k total citations · 2 hit papers
32 papers, 1.6k citations indexed

About

Thomas Harbo is a scholar working on Neurology, Cellular and Molecular Neuroscience and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Thomas Harbo has authored 32 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Neurology, 17 papers in Cellular and Molecular Neuroscience and 7 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Thomas Harbo's work include Peripheral Neuropathies and Disorders (21 papers), Hereditary Neurological Disorders (17 papers) and Myasthenia Gravis and Thymoma (8 papers). Thomas Harbo is often cited by papers focused on Peripheral Neuropathies and Disorders (21 papers), Hereditary Neurological Disorders (17 papers) and Myasthenia Gravis and Thymoma (8 papers). Thomas Harbo collaborates with scholars based in Denmark, United States and Netherlands. Thomas Harbo's co-authors include Henning Andersen, John Brincks, Johannes Jakobsen, Lars Høj Markvardsen, Søren H. Sindrup, Pieter A. van Doorn, Michael P. Lunn, David R. Cornblath, Peter Van den Bergh and Jeffrey A. Allen and has published in prestigious journals such as SHILAP Revista de lepidopterología, Neurology and Journal of Neurology Neurosurgery & Psychiatry.

In The Last Decade

Thomas Harbo

30 papers receiving 1.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

European Academy of Neurology/Peripheral Nerve Society guideline on diagnosis and treatment of chronic inflammatory demyelinating polyradiculoneuropathy: Report of a joint Task Force—Second revision

2021 252 citations Peter Van den Bergh, Pieter A. van Doorn et al. Journal of the Peripheral Nervous System profile →
European Academy of Neurology/Peripheral Nerve Society guideline on diagnosis and treatment of chronic inflammatory demyelinating polyradiculoneuropathy: Report of a joint Task Force—Second revision

2021 237 citations Peter Van den Bergh, Pieter A. van Doorn et al. European Journal of Neurology profile →

Peers

Countries citing papers authored by Thomas Harbo

Since Specialization

Citations

This map shows the geographic impact of Thomas Harbo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas Harbo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas Harbo more than expected).

Fields of papers citing papers by Thomas Harbo

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Thomas Harbo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas Harbo. The network helps show where Thomas Harbo may publish in the future.

Co-authorship network of co-authors of Thomas Harbo

This figure shows the co-authorship network connecting the top 25 collaborators of Thomas Harbo. A scholar is included among the top collaborators of Thomas Harbo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Thomas Harbo. Thomas Harbo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Neurophysiology and muscle histopathology in ICU-acquired muscle weakness: Lessons learned from COVID-19 2025 ·Clinical Neurophysiology Practice ·Eva Kildall Hejbøl, (unknown), Henrik Daa Schrøder, (unknown), Thomas Harbo, Hatice Tankişi	0
2	A Practical Guide to Identify Patients With Multifocal Motor Neuropathy, a Treatable Immune-Mediated Neuropathy 2024 ·SHILAP Revista de lepidopterología ·Jeffrey A. Allen, (unknown), Thomas Harbo	2
3	A population-based follow-up study of maximal muscle strength and mobility in patients with myasthenia gravis 2022 ·Neuromuscular Disorders ·(unknown), Lotte Vinge, Thomas Harbo, Henning Andersen	2
4	European Academy of Neurology/Peripheral Nerve Society guideline on diagnosis and treatment of chronic inflammatory demyelinating polyradiculoneuropathy: Report of a joint Task Force—Second revision breakdown → 2021 ·Journal of the Peripheral Nervous System ·Peter Van den Bergh, Pieter A. van Doorn, Robert D. M. Hadden, Bert Avau, Patrik Vankrunkelsven, Jeffrey A. Allen, Shahram Attarian, (unknown), David R. Cornblath, Filip Eftimov, H. Stephan Goedee, Thomas Harbo, Satoshi Kuwabara, Richard A. Lewis, Michael P. Lunn, Eduardo Nobile‐Orazio, Luís Querol, Yusuf A. Rajabally, Claudia Sommer, Haluk Topaloğlu	252
5	Myopathic changes in patients with long-term fatigue after COVID-19 2021 ·Clinical Neurophysiology ·Jane Agergaard, Steffen Leth, Thomas Holm Pedersen, Thomas Harbo, Jakob Udby Blicher, Páll Karlsson, Lars Østergaard, Henning Andersen, Hatice Tankişi	58
6	Intravenous immunoglobulin treatment for mild Guillain-Barré syndrome: an international observational study 2021 ·Journal of Neurology Neurosurgery & Psychiatry ·(unknown), Thomas Harbo, David R. Cornblath, Richard AC Hughes, Pieter A. van Doorn, Michael P. Lunn, Kenneth C. Gorson, Fábio Barroso, Satoshi Kuwabara, Giuliana Galassi, Helmar C. Lehmann, Susumu Kusunoki, Ricardo Reisin, Davide Binda, Guido Cavaletti, Bart C. Jacobs	11
7	European Academy of Neurology/Peripheral Nerve Society guideline on diagnosis and treatment of chronic inflammatory demyelinating polyradiculoneuropathy: Report of a joint Task Force—Second revision breakdown → 2021 ·European Journal of Neurology ·Peter Van den Bergh, Pieter A. van Doorn, Robert D. M. Hadden, Bert Avau, Patrik Vankrunkelsven, Jeffrey A. Allen, Shahram Attarian, (unknown), David R. Cornblath, Filip Eftimov, H. Stephan Goedee, Thomas Harbo, Satoshi Kuwabara, Richard A. Lewis, Michael P. Lunn, Eduardo Nobile‐Orazio, Luís Querol, Yusuf A. Rajabally, Claudia Sommer, Haluk Topaloğlu	237
8	Original research: Second IVIg course in Guillain-Barré syndrome with poor prognosis: the non-randomised ISID study 2019 ·Journal of Neurology Neurosurgery & Psychiatry ·(unknown), Bianca van den Berg, David R. Cornblath, Esmée Venema, Kenneth C. Gorson, Michael P. Lunn, Hester F. Lingsma, Peter Van den Bergh, Thomas Harbo, Kathleen Bateman, Yann Péréon, Søren H. Sindrup, Susumu Kusunoki, James Miller, Zhahirul Islam, Hans-Peter Hartung, Govindsinh Chavada, Bart C. Jacobs, Richard AC Hughes, Pieter A. van Doorn	33
9	Subcutaneous Immunoglobulin in Chronic Inflammatory Demyelinating Polyneuropathy – Neurologist, Nursing and Patient Perspectives 2019 ·European Neurological Review ·Hans Katzberg, Richard A. Lewis, Thomas Harbo, Jeffrey A. Allen, (unknown), (unknown), (unknown), (unknown), Vera Bril	2
10	Guillain–Barré syndrome in Denmark: a population-based study on epidemiology, diagnosis and clinical severity 2018 ·Journal of Neurology ·(unknown), Søren H. Sindrup, Henning Andersen, (unknown), Lisbeth Lassen, Bianca van den Berg, Bart C. Jacobs, Thomas Harbo	26
11	Igpro20, the Polyneuropathy and Treatment with Hizentra ^® Study (Path), and the Treatment of Chronic Inflammatory Demyelinating Polyradiculoneuropathy with Subcutaneous Igg 2018 ·Immunotherapy ·Melvin Berger, Thomas Harbo, David R. Cornblath, Orell Mielke	9
12	International Guillain‐Barré Syndrome Outcome Study: protocol of a prospective observational cohort study on clinical and biological predictors of disease course and outcome in Guillain‐Barré syndrome 2017 ·Journal of the Peripheral Nervous System ·Bart C. Jacobs, Bianca van den Berg, (unknown), Govindsinh Chavada, David R. Cornblath, Kenneth C. Gorson, Thomas Harbo, Hans‐Peter Hartung, Richard AC Hughes, Susumu Kusunoki, Pieter A. van Doorn, Hugh J. Willison	62
13	Subcutaneous immunoglobulin treatment in CIDP and MMN. Efficacy, treatment satisfaction and costs 2017 ·Journal of the Neurological Sciences ·Lars Høj Markvardsen, Thomas Harbo	37
14	Haemolytic anaemia as a complication to intravenous immunoglobulin infusion 2012 ·Lars Høj Markvardsen, Thomas Harbo, (unknown), Johannes Jakobsen	1
15	The effect of IgG levels on the number of natural killer cells and their Fc receptors in chronic inflammatory demyelinating polyradiculoneuropathy 2011 ·European Journal of Neurology ·(unknown), Line Nederby, Thomas Harbo, Anni Skovbo, Thomas Vorup‐Jensen, Jan Krog, Johannes Jakobsen, Marianne Hokland	23
16	Maximal isokinetic and isometric muscle strength of major muscle groups related to age, body mass, height, and sex in 178 healthy subjects 2011 ·European Journal of Applied Physiology ·Thomas Harbo, John Brincks, Henning Andersen	280
17	Subcutaneous versus intravenous immunoglobulin in multifocal motor neuropathy: a randomized, single‐blinded cross‐over trial 2009 ·European Journal of Neurology ·Thomas Harbo, Henning Andersen, (unknown), Klaus Hansen, Søren H. Sindrup, Janus Christian Jakobsen	107
18	Acute motor response following a single IVIG treatment course in chronic inflammatory demyelinating polyneuropathy 2009 ·Muscle & Nerve ·Thomas Harbo, Henning Andersen, Johannes Jakobsen	23
19	Length‐dependent weakness and electrophysiological signs of secondary axonal loss in chronic inflammatory demyelinating polyradiculoneuropathy 2008 ·Muscle & Nerve ·Thomas Harbo, Henning Andersen, Johannes Jakobsen	38
20	Muscle performance relates to physical function and quality of life in long‐term chronic inflammatory demyelinating polyradiculoneuropathy 2008 ·Journal of the Peripheral Nervous System ·Thomas Harbo, Henning Andersen, Kristian Overgaard, Johannes Jakobsen	28

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact